MINT-PERINDOPRIL
As listed in the register: MINT-PERINDOPRIL
4 mg · tablet
- Prescription only
- Heart, blood pressure and circulation
- Active substance
- Perindopril Erbumine
- Made by
- Mint Pharmaceuticals Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Perindopril Erbumine). It describes the substance, not this exact product.
Perindopril erbumine is a pro-drug for perindoprilat, which inhibits ACE in human subjects and animals.
The mechanism through which perindoprilat lowers blood pressure is believed to be primarily inhibition of ACE activity.
Perindopril is extensively metabolized following oral administration, with only 4 to 12% of the dose recovered unchanged in the urine.
Oral administration of perindopril erbumine with food does not significantly lower the rate or extent of perindopril absorption relative to the fasted state.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2024-03-13
Safety of the active substance
From the US prescribing label for the same active substance (Perindopril Erbumine). It describes the substance, not this exact product.
WARNING: FETAL TOXICITY When pregnancy is detected, discontinue perindopril erbumine as soon as possible [see Warnings and Precautions (5.4) ].
- Perindopril erbumine tablets are contraindicated in patients known to be hypersensitive (including angioedema) to this product or to any other ACE inhibitor.
- Perindopril erbumine tablets are also contraindicated in patients with hereditary or idiopathic angioedema.
- Do not co-administer aliskiren with perindopril erbumine tablets in patients with diabetes. [see Drug Interactions (7.8) ] Perindopril erbumine tablets are contraindicated in combination with neprilysin inhibitor (e.g., sacubitril).
- Do not administer perindopril erbumine tablets within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor [see Warnings and Precautions (5.1) ].
Most common adverse events (incidence greater than or equal to 5%) are cough, dizziness and back pain.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Spain7 matching products
Netherlands8 matching products
- Perindopril tert-butylamine Aurobindo 4 mg 4 mg · tablet
- Perindopril tert-butylamine DOC Generici 4 mg 4 mg · tablet
- Perindopril tert-butylamine Glenmark 4 mg 4 mg · tablet
- Perindopril tert-butylamine Glenmark 4 mg tabletten 4 mg · tablet
- Perindopril tert-butylamine Sandoz 4 mg 4 mg · tablet
- Perindopril tert-butylamine SUN 4 mg tabletten 4 mg · tablet
- Perindopril tert-butylamine Teva 4 mg 4 mg · tablet
- Perindopril tert-butylamine Viatris 4 mg 4 mg · tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Mint Pharmaceuticals Inc |
|---|---|
| Active substance | Perindopril Erbumine |
| Used in | Heart, blood pressure and circulation |
| Strength | 4 mg |
| Form | tablet |
| Classification | C09AA04 · Heart, blood pressure and circulation |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02476770 |
| DPD drug code | 96761 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.